DNMT1 and ovarian carcinoma: As reported that the high expression of DNMT1 supported the potential contribution of ovarian cancer stem cells to platinum resistance [21], we performed drug sensitivity assays by CCK8 with cisplatin (DDP) which are commonly used of chemotherapy for ESCC.